• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STAT3 转录因子促进急性移植物抗宿主病期间 nTreg 细胞的不稳定性,并限制 iTreg 细胞的生成。

STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.

机构信息

Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Immunity. 2012 Aug 24;37(2):209-22. doi: 10.1016/j.immuni.2012.05.027.

DOI:10.1016/j.immuni.2012.05.027
PMID:22921119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3441059/
Abstract

Acute graft-versus-host disease (GvHD) is a major cause of mortality in allogeneic bone marrow transplantation (BMT), for which administration of FoxP3(+) regulatory T (Treg) cells has been proposed as a therapy. However, the phenotypic stability of Treg cells is controversial, and STAT3-dependent cytokines can inhibit FoxP3 expression. We assessed whether the elimination of STAT3 in T cells could limit the severity of GvHD. We found STAT3 limited FoxP3(+) Treg cell numbers following allogeneic BMT by two pathways: instability of natural Treg (nTreg) cells and inhibition of induced Treg (iTreg) cell polarization from naive CD4(+) T cells. Deletion of STAT3 within only the nTreg cell population was not sufficient to protect against lethal GvHD. In contrast, transfer of STAT3-deficient naive CD4(+) T cells increased FoxP3(+) Treg cells post-BMT and prevented lethality, suggesting that the consequence of STAT3 signaling may be greater for iTreg rather than nTreg cells during GvHD.

摘要

急性移植物抗宿主病 (GvHD) 是异基因骨髓移植 (BMT) 患者死亡的主要原因,已有研究提出,FoxP3(+)调节性 T (Treg) 细胞的输注可能是一种有效的治疗方法。然而,Treg 细胞的表型稳定性存在争议,STAT3 依赖性细胞因子可抑制 FoxP3 的表达。我们评估了 T 细胞中 STAT3 的缺失是否可以限制 GvHD 的严重程度。我们发现,在异基因 BMT 后,STAT3 通过两种途径限制 FoxP3(+)Treg 细胞的数量:天然 Treg(nTreg)细胞的不稳定性和初始 CD4(+)T 细胞向诱导性 Treg(iTreg)细胞极化的抑制。仅在 nTreg 细胞群中缺失 STAT3 不足以预防致死性 GvHD。相比之下,STAT3 缺陷的初始 CD4(+)T 细胞的转移增加了 BMT 后 FoxP3(+)Treg 细胞的数量,并预防了致死性,这表明在 GvHD 期间,STAT3 信号的后果可能对 iTreg 细胞比对 nTreg 细胞更大。

相似文献

1
STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.STAT3 转录因子促进急性移植物抗宿主病期间 nTreg 细胞的不稳定性,并限制 iTreg 细胞的生成。
Immunity. 2012 Aug 24;37(2):209-22. doi: 10.1016/j.immuni.2012.05.027.
2
Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease.Foxp3 表达的不稳定性限制了诱导性调节 T 细胞减轻移植物抗宿主病的能力。
Clin Cancer Res. 2011 Jun 15;17(12):3969-83. doi: 10.1158/1078-0432.CCR-10-3347. Epub 2011 May 10.
3
Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.信号转导与转录激活因子3(STAT3)在CD4+CD25+FOXP3+调节性淋巴细胞生成中的作用:对移植物抗宿主病和抗肿瘤免疫的影响
J Immunol. 2007 Dec 1;179(11):7593-604. doi: 10.4049/jimmunol.179.11.7593.
4
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.宿主自然杀伤T细胞诱导供体CD4+CD25+Foxp3+调节性T细胞的白细胞介素-4依赖性扩增,从而预防移植物抗宿主病。
Blood. 2009 Apr 30;113(18):4458-67. doi: 10.1182/blood-2008-06-165506. Epub 2009 Feb 12.
5
Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.受者髓系来源的免疫调节细胞诱导 PD-1 配体依赖性供体 CD4+Foxp3+调节性 T 细胞增殖和小鼠非清髓性骨髓移植后的供体-受者免疫耐受。
J Immunol. 2013 Dec 1;191(11):5764-76. doi: 10.4049/jimmunol.1302191. Epub 2013 Nov 4.
6
Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.同种异体抗原特异性新诱导的 Foxp3+Treg 在体内逆转,不能预防实验性移植物抗宿主病。
Eur J Immunol. 2009 Nov;39(11):3091-6. doi: 10.1002/eji.200939432.
7
CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.移植物抗宿主病过程中诱导产生 CD8+Foxp3+调节性 T 细胞,减轻疾病严重程度。
J Immunol. 2012 Jul 1;189(1):464-74. doi: 10.4049/jimmunol.1200886. Epub 2012 May 30.
8
Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.通过连锁抑制在小鼠中通过抗原特异性诱导的 Tregs 进行高效和选择性的移植物抗宿主病预防。
Biol Blood Marrow Transplant. 2011 Mar;17(3):309-18. doi: 10.1016/j.bbmt.2010.12.710. Epub 2011 Jan 9.
9
[Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].[小鼠基因工程调节性T细胞输注对小鼠异基因骨髓移植后急性移植物抗宿主病的影响]
Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):83-8.
10
Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.在小鼠急性移植物抗宿主病模型中,使用间充质干细胞和调节性T细胞的联合细胞疗法可提供一种协同免疫调节作用,该作用与TH1/TH2和Th17/Treg细胞的相互调节相关。
Cell Transplant. 2014 Apr;23(6):703-14. doi: 10.3727/096368913X664577. Epub 2013 Feb 26.

引用本文的文献

1
PD-1 receptor deficiency enhances CD30 T cell function in melanoma.程序性死亡受体1(PD-1)受体缺陷增强黑色素瘤中CD30阳性T细胞的功能。
Nat Immunol. 2025 Jun 2. doi: 10.1038/s41590-025-02172-0.
2
[Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice].[供体T细胞Stat3缺陷对小鼠急性肠道移植物抗宿主病的影响]
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):302-313. doi: 10.3760/cma.j.cn121090-20250107-00011.
3
Evaluating Axatilimab as a treatment option for chronic graft-versus-host disease.评估阿沙替利单抗作为慢性移植物抗宿主病的一种治疗选择。

本文引用的文献

1
Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.Foxp3(+) T 细胞的可塑性反映了常规 T 细胞中 Foxp3 的混杂表达,而不是调节性 T 细胞的重新编程。
Immunity. 2012 Feb 24;36(2):262-75. doi: 10.1016/j.immuni.2011.12.012. Epub 2012 Feb 9.
2
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.移植中 CD4(+)Foxp3(+) 调节性 T 细胞治疗。
J Mol Cell Biol. 2012 Feb;4(1):11-21. doi: 10.1093/jmcb/mjr047. Epub 2011 Dec 14.
3
IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
Immunotherapy. 2025 Apr;17(6):409-418. doi: 10.1080/1750743X.2025.2501928. Epub 2025 May 8.
4
Echinococcus granulosus antigen B regulates T-cell function through inhibition of signal transducer and activator of transcription 3 in experimental immune thrombocytopenia.细粒棘球绦虫抗原B通过抑制信号转导和转录激活因子3来调节实验性免疫性血小板减少症中的T细胞功能。
Br J Haematol. 2025 Jun;206(6):1627-1641. doi: 10.1111/bjh.20064. Epub 2025 May 5.
5
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs.Th17细胞中NLRP3的内在表达促进了它们的促肿瘤活性以及向调节性T细胞的转化。
Cell Mol Immunol. 2025 May;22(5):541-556. doi: 10.1038/s41423-025-01281-y. Epub 2025 Apr 7.
6
ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development.依赖活性氧的细胞因子信号转导抑制因子3上调在自身免疫性疾病发展过程中破坏调节性T细胞稳定性。
Redox Biol. 2025 May;82:103590. doi: 10.1016/j.redox.2025.103590. Epub 2025 Mar 10.
7
The TET-TDG axis in T cells and biological processes.T细胞中的TET-TDG轴与生物学过程。
Int Immunol. 2025 May 21;37(6):299-312. doi: 10.1093/intimm/dxaf006.
8
Targeting p97-Npl4 interaction inhibits tumor T cell development to enhance tumor immunity.靶向 p97-Npl4 相互作用抑制肿瘤 T 细胞发育以增强肿瘤免疫。
Nat Immunol. 2024 Sep;25(9):1623-1636. doi: 10.1038/s41590-024-01912-y. Epub 2024 Aug 6.
9
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.功能重编程的调节性 T 细胞(Tregs)产生 IFNγ 可增强 OX40/CD137 双特异性激动剂疗法的抗肿瘤疗效。
Cancer Res Commun. 2024 Aug 1;4(8):2045-2057. doi: 10.1158/2767-9764.CRC-23-0500.
10
STAT activation in regulatory CD4 T cells of patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者调节性 CD4 T 细胞中的 STAT 激活。
Immun Inflamm Dis. 2024 Apr;12(4):e1248. doi: 10.1002/iid3.1248.
白细胞介素-2(IL-2)控制体内 TGF-β诱导的 Foxp3+T 细胞中 Foxp3 表达的稳定性。
J Immunol. 2011 Jun 1;186(11):6329-37. doi: 10.4049/jimmunol.1100061. Epub 2011 Apr 27.
4
Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.调节性 T 细胞中的白细胞介素-10 信号传导对于抑制 Th17 细胞介导的炎症是必需的。
Immunity. 2011 Apr 22;34(4):566-78. doi: 10.1016/j.immuni.2011.03.018.
5
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.Th17 细胞表达白细胞介素-10 受体,并通过白细胞介素-10 依赖的方式受 Foxp3⁻ 和 Foxp3+ 调节性 CD4+T 细胞的控制。
Immunity. 2011 Apr 22;34(4):554-65. doi: 10.1016/j.immuni.2011.01.020.
6
Regulatory T cells: history and perspective.调节性T细胞:历史与展望。
Methods Mol Biol. 2011;707:3-17. doi: 10.1007/978-1-61737-979-6_1.
7
Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.Th17 细胞分化中的信号转导途径和转录调控。
Cytokine Growth Factor Rev. 2010 Dec;21(6):425-34. doi: 10.1016/j.cytogfr.2010.10.006. Epub 2010 Nov 16.
8
Stability of the regulatory T cell lineage in vivo.体内调节性 T 细胞谱系的稳定性。
Science. 2010 Sep 24;329(5999):1667-71. doi: 10.1126/science.1191996.
9
Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I.Foxp3 基因的正、负转录调控是由 Smad3 蛋白与增强子 I 的进入和结合介导的。
Immunity. 2010 Sep 24;33(3):313-25. doi: 10.1016/j.immuni.2010.09.001.
10
Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.转录因子 STAT3 的多种靶标有助于 T 细胞的致病性和稳态。
Immunity. 2010 May 28;32(5):605-15. doi: 10.1016/j.immuni.2010.05.003. Epub 2010 May 20.